Lv6
3050 积分 2023-07-31 加入
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
20天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2个月前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
2个月前
已完结
SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial
2个月前
已完结
Pancreatic cancer
3个月前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
3个月前
已完结
Immune checkpoint inhibitor–related colitis in patients on immunotherapy for cancer
3个月前
已完结
Immunotherapy related colitis
3个月前
已关闭
Immunotherapy-induced Colitis
3个月前
已完结
Primary Cutaneous Peripheral T-Cell Lymphoma NOS: Diagnostic Criteria and Challenges
4个月前
已完结
皖公网安备34019202002308
